Clinics in dermatology · 2025
Microneedling radiofrequency followed by topical exosome application therapy for pattern hair loss: A scoping review and prospective study.
СтатьяScoping ReviewНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Koumprentziotis Ioannis-Alexios, Kroumpouzos Eleni, Delavar Shohreh, Kroumpouzos George
Аннотация
Microneedling radiofrequency (MNRF) and exosome therapies have recently garnered attention as potential treatments for pattern hair loss (PHL). This study aimed to conduct a scoping review of these treatments and present a series of patients with PHL treated with MNRF followed by topical exosome application therapy. We searched the PubMed, Google Scholar, and Cochrane databases for relevant articles regarding MNRF and exosome treatments for PHL. Our search yielded two studies on MNRF and nine studies on exosome therapy, all of which demonstrated positive effects on hair regrowth. One of these studies specifically focused on MN combined with exosome therapy. In our current study, we prospectively evaluated the efficacy and safety of MNRF followed by topical exosome application in 20 patients (median age, 46 years), comprising 16 men and four women, with PHL. Clinical evaluations were conducted using macroscopic photographs and digital image analysis with a trichoscopy device at baseline and then again at three, six, and nine months after treatment. The median followup duration was 10 months. Our results revealed significant increases in mean hair density and diameter, along with high patient satisfaction. No adverse events were reported. The treatment response was found to be independent of sex and the severity of PHL. Overall, this study underscores the potential therapeutic benefits of the MNRF followed by topical exosome application therapy. Randomized controlled trials, however, are needed to confirm the efficacy of this therapy and to determine the optimal treatment parameters.